아타자나비르 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "아타자나비르" in Korean language version.

refsWebsite

Global rank Korean rank

6doi.org

2^nd place

3^rd place

5web.archive.org

1^st place

4worldcat.org

5^th place

11^th place

4nih.gov

4^th place

1drugs.com

399^th place

141^st place

1handle.net

102^nd place

307^th place

1mshpriceguide.org

low place

2,329^th place

1fda.gov

447^th place

433^rd place

1drugbank.ca

4,294^th place

1,811^th place

doi.org (Global: 2^nd place; Korean: 3^rd place)

dx.doi.org

Croom, KF; Dhillon, S; Keam, SJ (2009). “Atazanavir: A Review of its Use in the Management of HIV-1 Infection”. 《Drugs》 69 (8): 1107–1140. doi:10.2165/00003495-200969080-00009. PMID 19496633.
Bold, Guido; Fässler, Alexander; Capraro, Hans-Georg; Cozens, Robert; Klimkait, Thomas; Lazdins, Janis; Mestan, Jürgen; Poncioni, Bernard; Rösel, Johannes (1998년 8월 1일). “New Aza-Dipeptide Analogues as Potent and Orally Absorbed HIV-1 Protease Inhibitors: Candidates for Clinical Development”. 《Journal of Medicinal Chemistry》 41 (18): 3387–3401. doi:10.1021/jm970873c. ISSN 0022-2623.
Bold, Guido; Fässler, Alexander; Capraro, Hans-Georg; Cozens, Robert; Klimkait, Thomas; Lazdins, Janis; Mestan, Jürgen; Poncioni, Bernard; Rösel, Johannes (1998년 8월 1일). “New Aza-Dipeptide Analogues as Potent and Orally Absorbed HIV-1 Protease Inhibitors: Candidates for Clinical Development”. 《Journal of Medicinal Chemistry》 41 (18): 3387–3401. doi:10.1021/jm970873c. ISSN 0022-2623.
Perazzolo, Simone; Shireman, Laura M.; Koehn, Josefin; McConnachie, Lisa A.; Kraft, John C.; Shen, Danny D.; Ho, Rodney J.Y. (2018년 12월). “Three HIV Drugs, Atazanavir, Ritonavir, and Tenofovir, Coformulated in Drug-Combination Nanoparticles Exhibit Long-Acting and Lymphocyte-Targeting Properties in Nonhuman Primates”. 《Journal of pharmaceutical sciences》 107 (12): 3153–3162. doi:10.1016/j.xphs.2018.07.032. ISSN 0022-3549. PMC 6553477. PMID 30121315.

doi.org

Bold, Guido; Fässler, Alexander; Capraro, Hans-Georg; Cozens, Robert; Klimkait, Thomas; Lazdins, Janis; Mestan, Jürgen; Poncioni, Bernard; Rösel, Johannes (1998년 8월 1일). “New Aza-Dipeptide Analogues as Potent and Orally Absorbed HIV-1 Protease Inhibitors: Candidates for Clinical Development”. 《Journal of Medicinal Chemistry》 41 (18): 3387–3401. doi:10.1021/jm970873c. ISSN 0022-2623.
Bold, Guido; Fässler, Alexander; Capraro, Hans-Georg; Cozens, Robert; Klimkait, Thomas; Lazdins, Janis; Mestan, Jürgen; Poncioni, Bernard; Rösel, Johannes (1998년 8월 1일). “New Aza-Dipeptide Analogues as Potent and Orally Absorbed HIV-1 Protease Inhibitors: Candidates for Clinical Development”. 《Journal of Medicinal Chemistry》 41 (18): 3387–3401. doi:10.1021/jm970873c. ISSN 0022-2623.

drugbank.ca (Global: 4,294^th place; Korean: 1,811^th place)

“Atazanavir”. 《DrugBank》. 2016년 11월 9일. 2016년 11월 9일에 원본 문서에서 보존된 문서.

drugs.com (Global: 399^th place; Korean: 141^st place)

“Atazanavir Sulfate”. The American Society of Health-System Pharmacists. 2016년 12월 20일에 원본 문서에서 보존된 문서. 2016년 11월 28일에 확인함.

fda.gov (Global: 447^th place; Korean: 433^rd place)

accessdata.fda.gov

“Reyataz Package Insert” (PDF). 《Drugs@FDA》. Food and Drug Administration. September 2016. 2016년 11월 11일에 원본 문서 (PDF)에서 보존된 문서. 2016년 11월 10일에 확인함.

handle.net (Global: 102^nd place; Korean: 307^th place)

hdl.handle.net

World Health Organization (2019). 《World Health Organization model list of essential medicines: 21st list 2019》. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

mshpriceguide.org (Global: low place; Korean: 2,329^th place)

“Atazanavir”. 《International Drug Price Indicator Guide》. 2018년 1월 22일에 원본 문서에서 보존된 문서. 2016년 11월 28일에 확인함.

nih.gov (Global: 4^th place; Korean: 4^th place)

ncbi.nlm.nih.gov

Croom, KF; Dhillon, S; Keam, SJ (2009). “Atazanavir: A Review of its Use in the Management of HIV-1 Infection”. 《Drugs》 69 (8): 1107–1140. doi:10.2165/00003495-200969080-00009. PMID 19496633.
Kohl, N E; Emini, E A; Schleif, W A; Davis, L J; Heimbach, J C; Dixon, R A; Scolnick, E M; Sigal, I S (1988년 7월). “Active human immunodeficiency virus protease is required for viral infectivity.”. 《Proceedings of the National Academy of Sciences of the United States of America》 85 (13): 4686–4690. ISSN 0027-8424. PMID 3290901.
Perazzolo, Simone; Shireman, Laura M.; Koehn, Josefin; McConnachie, Lisa A.; Kraft, John C.; Shen, Danny D.; Ho, Rodney J.Y. (2018년 12월). “Three HIV Drugs, Atazanavir, Ritonavir, and Tenofovir, Coformulated in Drug-Combination Nanoparticles Exhibit Long-Acting and Lymphocyte-Targeting Properties in Nonhuman Primates”. 《Journal of pharmaceutical sciences》 107 (12): 3153–3162. doi:10.1016/j.xphs.2018.07.032. ISSN 0022-3549. PMC 6553477. PMID 30121315.

aidsinfo.nih.gov

“What's New in the Guidelines? | Adult and Adolescent ARV Guidelines | AIDSinfo”. 《AIDSinfo》. 2016년 11월 15일에 원본 문서에서 보존된 문서. 2016년 11월 10일에 확인함.

web.archive.org (Global: 1^st place; Korean: 1^st place)

“Atazanavir Sulfate”. The American Society of Health-System Pharmacists. 2016년 12월 20일에 원본 문서에서 보존된 문서. 2016년 11월 28일에 확인함.
“Atazanavir”. 《International Drug Price Indicator Guide》. 2018년 1월 22일에 원본 문서에서 보존된 문서. 2016년 11월 28일에 확인함.
“What's New in the Guidelines? | Adult and Adolescent ARV Guidelines | AIDSinfo”. 《AIDSinfo》. 2016년 11월 15일에 원본 문서에서 보존된 문서. 2016년 11월 10일에 확인함.
“Reyataz Package Insert” (PDF). 《Drugs@FDA》. Food and Drug Administration. September 2016. 2016년 11월 11일에 원본 문서 (PDF)에서 보존된 문서. 2016년 11월 10일에 확인함.
“Atazanavir”. 《DrugBank》. 2016년 11월 9일. 2016년 11월 9일에 원본 문서에서 보존된 문서.

worldcat.org (Global: 5^th place; Korean: 11^th place)

Bold, Guido; Fässler, Alexander; Capraro, Hans-Georg; Cozens, Robert; Klimkait, Thomas; Lazdins, Janis; Mestan, Jürgen; Poncioni, Bernard; Rösel, Johannes (1998년 8월 1일). “New Aza-Dipeptide Analogues as Potent and Orally Absorbed HIV-1 Protease Inhibitors: Candidates for Clinical Development”. 《Journal of Medicinal Chemistry》 41 (18): 3387–3401. doi:10.1021/jm970873c. ISSN 0022-2623.
Kohl, N E; Emini, E A; Schleif, W A; Davis, L J; Heimbach, J C; Dixon, R A; Scolnick, E M; Sigal, I S (1988년 7월). “Active human immunodeficiency virus protease is required for viral infectivity.”. 《Proceedings of the National Academy of Sciences of the United States of America》 85 (13): 4686–4690. ISSN 0027-8424. PMID 3290901.
Bold, Guido; Fässler, Alexander; Capraro, Hans-Georg; Cozens, Robert; Klimkait, Thomas; Lazdins, Janis; Mestan, Jürgen; Poncioni, Bernard; Rösel, Johannes (1998년 8월 1일). “New Aza-Dipeptide Analogues as Potent and Orally Absorbed HIV-1 Protease Inhibitors: Candidates for Clinical Development”. 《Journal of Medicinal Chemistry》 41 (18): 3387–3401. doi:10.1021/jm970873c. ISSN 0022-2623.
Perazzolo, Simone; Shireman, Laura M.; Koehn, Josefin; McConnachie, Lisa A.; Kraft, John C.; Shen, Danny D.; Ho, Rodney J.Y. (2018년 12월). “Three HIV Drugs, Atazanavir, Ritonavir, and Tenofovir, Coformulated in Drug-Combination Nanoparticles Exhibit Long-Acting and Lymphocyte-Targeting Properties in Nonhuman Primates”. 《Journal of pharmaceutical sciences》 107 (12): 3153–3162. doi:10.1016/j.xphs.2018.07.032. ISSN 0022-3549. PMC 6553477. PMID 30121315.

아타자나비르 (Korean Wikipedia)

doi.org (Global: 2nd place; Korean: 3rd place)

dx.doi.org

doi.org

drugbank.ca (Global: 4,294th place; Korean: 1,811th place)

drugs.com (Global: 399th place; Korean: 141st place)

fda.gov (Global: 447th place; Korean: 433rd place)